Aurinia Pharmaceuticals
AUPH
AUPH
199 hedge funds and large institutions have $510M invested in Aurinia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.32% more ownership
Funds ownership: 30.48% → 35.8% (+5.3%)
4% less capital invested
Capital invested by funds: $533M → $510M (-$22.5M)
Holders
199
Holding in Top 10
1
Calls
$34.3M
Puts
$22.7M
Top Buyers
| 1 | +$66.9M | |
| 2 | +$20.8M | |
| 3 | +$11.8M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$10.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.14M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$12.2M | |
| 3 | -$8.71M | |
| 4 |
Millennium Management
New York
|
-$8.08M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$4.8M |